PSMC2 Antibodies

Santa Cruz Biotechnology provides a broad selection of PSMC2 monoclonal antibodies for research focused on understanding PSMC2 protein functions. PSMC2 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PSMC2, also known as proteasome 26S subunit, ATPase 2, is a crucial component of the 26S proteasome, which is responsible for the degradation of ubiquitinated proteins. PSMC2 plays a significant role in regulating various cellular processes, including the cell cycle, apoptosis, and the response to oxidative stress. Research has shown that PSMC2 is involved in diseases such as cancer and neurodegenerative disorders. Investigating PSMC2 can provide valuable information about cellular protein degradation pathways and their impact on disease progression. Understanding PSMC2 function helps researchers develop new therapeutic strategies for treating proteasome-related disorders. Exploring PSMC2's role in protein degradation pathways continues to reveal new insights into cellular homeostasis and disease mechanisms. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance their understanding of PSMC2 and its implications in human health and disease.